University Hospital Ulm

Ulm 89081

3 studies enrolling now · 14 studies all time

What they study most

Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), Cardiovascular Diseases, Cardiovascular Risk Factors, Childhood Teratoma, Choriocarcinoma, Colitis, Ulcerative, Colon Adenocarcinoma, DNA Repair Disorder, Dedifferentiated Liposarcoma, Diffuse Cutaneous Systemic Sclerosis, Extragonadal Seminoma

Studies at this site

• The Oxford Risk Factors And Non-Invasive Imaging Study — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis — Recruiting now
• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair — Running, not enrolling
• A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. — Running, not enrolling
• Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors — Running, not enrolling
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC — Running, not enrolling
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC — Status unconfirmed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis — Stopped early
• PHysical Activity and Exercise Outcomes in Huntington's Disease — Status unconfirmed
• Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler — Stopped early